Note: This article is for general education only and is not a substitute for medical advice, diagnosis, or treatment. Skyrizi is a prescription biologic, so any decision to start, stop, delay, or switch treatment should be made with a licensed healthcare professional.
Introduction: Why People Ask About Skyrizi and Cancer Risk
Skyrizi sounds like a medication name invented by someone who wanted a drug and a vacation resort to share the same branding. But behind the airy name is a serious prescription biologic used for serious inflammatory conditions, including moderate to severe plaque psoriasis, active psoriatic arthritis, moderate to severe Crohn’s disease, and moderate to severe ulcerative colitis in adults.
The active ingredient in Skyrizi is risankizumab-rzaa, an interleukin-23 inhibitor. In plain English, it targets a specific immune-system protein called IL-23 that helps drive inflammation. By calming that pathway, Skyrizi may reduce plaques, joint inflammation, bowel inflammation, and flare activity in people whose immune systems are acting like an overcaffeinated security guard.
Because Skyrizi affects the immune system, many patients naturally ask: Does Skyrizi cause cancer? It is a fair question. Any medication that changes immune activity deserves a careful look, especially for people with a personal history of cancer, family cancer concerns, frequent infections, or previous use of other immune-modifying drugs.
The short answer is: Skyrizi is not currently known to cause cancer, and cancer is not listed as a common side effect in U.S. prescribing information. However, that does not mean every patient has the same risk profile. Cancer risk is influenced by many things, including age, genetics, smoking, sun exposure, chronic inflammation, previous immunosuppressive therapy, and the underlying disease being treated.
This guide explains Skyrizi cancer risk, common and serious side effects, warning signs, safety monitoring, and practical patient experiences in a clear, human wayno medical fog machine required.
What Is Skyrizi?
Skyrizi is a biologic medication, meaning it is made from living cells rather than being chemically manufactured like many traditional pills. It belongs to a class of medications called interleukin-23 inhibitors. IL-23 is involved in inflammatory signaling, and blocking it can help reduce the immune overactivity seen in psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis.
Conditions Skyrizi Is Used to Treat
In the United States, Skyrizi is prescribed for adults with:
- Moderate to severe plaque psoriasis who may benefit from systemic therapy or phototherapy
- Active psoriatic arthritis
- Moderately to severely active Crohn’s disease
- Moderately to severely active ulcerative colitis
For plaque psoriasis and psoriatic arthritis, Skyrizi is usually given as a subcutaneous injection at Week 0, Week 4, and then every 12 weeks. For Crohn’s disease and ulcerative colitis, treatment typically begins with intravenous induction doses, followed by maintenance injections under the skin every 8 weeks. The exact dose and schedule depend on the condition being treated, your response, and your prescriber’s plan.
Does Skyrizi Cause Cancer?
At this time, Skyrizi is not known to cause cancer. U.S. prescribing information does not list cancer as a common side effect, and Skyrizi does not carry a boxed warning for malignancy. That is an important distinction because some older immune-modifying medications and certain drug classes have stronger warnings related to serious infections or malignancies.
Still, the question is not silly. The immune system plays a role in identifying abnormal cells, and medications that change immune function can raise reasonable concerns. Skyrizi is more targeted than broad immunosuppressants because it focuses on the IL-23 pathway rather than shutting down the immune system like a power outage. But “targeted” does not mean “risk-free.” It means the risk conversation should be specific, not panic-driven.
What Current Evidence Suggests
Clinical trial and long-term safety data have not shown a clear cancer signal that proves Skyrizi causes cancer. Malignancies can occur in people taking Skyrizi, just as they can occur in people not taking it, especially in populations with chronic inflammatory diseases. The key question is whether the medication increases cancer rates beyond what would normally be expected. Current evidence has not established that Skyrizi meaningfully increases overall cancer risk.
However, long-term safety monitoring continues. That is normal for biologics. Many rare side effects only become clearer after a medication has been used by large numbers of people over many years. This is why doctors continue to monitor patients, review medical history, and report unexpected adverse events.
Who Should Be Extra Careful?
You should have a detailed conversation with your healthcare provider before using Skyrizi if you have:
- A personal history of cancer
- Recent cancer treatment or active cancer surveillance
- A strong family history of certain cancers
- Unexplained weight loss, swollen lymph nodes, or persistent fevers
- Heavy sun exposure or a history of skin cancer
- Previous use of other immune-suppressing medications
This does not automatically mean Skyrizi is off the table. It means your doctor may want to coordinate with your oncologist, dermatologist, gastroenterologist, or rheumatologist before making a decision. Medicine is not a vending machine; the best answer depends on the whole person.
Common Side Effects of Skyrizi
Most people want to know two things before starting a biologic: “Will it help?” and “Will it make me feel weird?” Skyrizi can cause side effects, although not everyone experiences them.
Common Side Effects in Plaque Psoriasis and Psoriatic Arthritis
The most commonly reported side effects in people treated for plaque psoriasis and psoriatic arthritis include:
- Upper respiratory infections, such as colds or sinus symptoms
- Headache
- Fatigue or tiredness
- Injection site reactions, such as redness, soreness, itching, or swelling
- Fungal skin infections, including tinea infections
These side effects are often mild to moderate, but they should still be taken seriously if they persist, worsen, or interfere with daily life. A “minor” side effect is only minor if it stays minor.
Common Side Effects in Crohn’s Disease and Ulcerative Colitis
For people using Skyrizi for Crohn’s disease or ulcerative colitis, common side effects may include:
- Upper respiratory infections
- Headache
- Joint pain
- Abdominal pain
- Injection site reactions
- Low red blood cells, also called anemia
- Fever
- Back pain
- Urinary tract infections
- Rash
Because Crohn’s disease and ulcerative colitis can also cause abdominal pain, fatigue, anemia, fever, and general “my body has filed a complaint” symptoms, it is important not to guess whether a symptom is from Skyrizi, the condition itself, another medication, or an infection. Report changes clearly and early.
Serious Side Effects and Warning Signs
Skyrizi may cause serious side effects, though they are less common than mild side effects. Knowing the warning signs can help you act quickly instead of playing the dangerous game of “maybe it will go away by Monday.”
Serious Allergic Reactions
Serious allergic reactions, including anaphylaxis, have been reported with Skyrizi. Get emergency medical help right away if you experience symptoms such as:
- Swelling of the face, lips, mouth, tongue, throat, or eyelids
- Trouble breathing or throat tightness
- Chest tightness
- Fainting, dizziness, or feeling lightheaded
- Hives, severe rash, or intense itching
Do not try to “walk off” breathing trouble or facial swelling. Your immune system is not asking for a pep talk; it is asking for urgent care.
Infections
Skyrizi can lower the immune system’s ability to fight infections and may increase infection risk. Before starting treatment, your healthcare provider should check for infections and tuberculosis. If you have active TB, Skyrizi should not be administered until that is properly addressed.
Tell your healthcare provider right away if you develop signs of infection, including:
- Fever, chills, or sweats
- Cough or shortness of breath
- Blood in mucus
- Muscle aches
- Warm, red, painful skin or sores
- Unexplained weight loss
- Diarrhea or stomach pain
- Burning during urination or urinating more often than usual
Your provider may delay a dose if you have a clinically important infection. That can be frustrating, especially if your symptoms were finally improving, but treating infection first is often the safer move.
Liver Problems in Crohn’s Disease and Ulcerative Colitis Treatment
For people receiving Skyrizi for Crohn’s disease or ulcerative colitis, liver monitoring matters. A serious case of drug-induced liver injury with rash and hospitalization was reported during induction treatment. Because of this, healthcare providers typically check liver enzymes and bilirubin before treatment and during the first 12 weeks of induction, then monitor as appropriate afterward.
Call your healthcare provider promptly if you notice symptoms that may suggest liver trouble, such as:
- Unexplained rash
- Nausea or vomiting
- Abdominal pain
- Unusual fatigue
- Loss of appetite
- Yellowing of the skin or eyes
- Dark urine
Vaccines, Pregnancy, and Other Safety Considerations
Live Vaccines
Live vaccines should generally be avoided right before, during, and right after Skyrizi treatment. Because Skyrizi interacts with the immune system, live vaccines may carry a higher infection risk. Before starting Skyrizi, ask your healthcare provider whether you should update routine vaccines, including flu, COVID-19, shingles, pneumonia, hepatitis, or other age-appropriate immunizations.
Pregnancy and Breastfeeding
It is not known whether Skyrizi can harm an unborn baby or whether it passes into breast milk. If you are pregnant, planning pregnancy, or breastfeeding, discuss the risks and benefits with your healthcare provider. Some patients may also be encouraged to enroll in a pregnancy registry if they become pregnant while using Skyrizi.
Medication Interactions
Always tell your provider about prescription drugs, over-the-counter medicines, vitamins, and supplements. This is especially important if you use corticosteroids, methotrexate, other biologics, JAK inhibitors, immune suppressants, or medications that may affect infection risk. Your doctor is not being nosy; they are trying to keep your treatment plan from turning into a chemistry experiment.
How to Reduce Risks While Taking Skyrizi
You cannot remove every risk from any medication, but you can reduce avoidable problems with a smart routine.
Before Starting Skyrizi
- Review your full medical history, including cancer, infections, liver disease, and TB exposure.
- Complete recommended TB screening.
- Update vaccines before treatment when appropriate.
- Ask whether baseline blood work is needed, especially for Crohn’s disease or ulcerative colitis.
- Discuss pregnancy plans before beginning therapy.
During Treatment
- Track infections, fevers, rashes, or unusual fatigue.
- Use injections exactly as instructed.
- Rotate injection sites and avoid irritated, bruised, tender, or affected skin.
- Keep all follow-up appointments and lab tests.
- Do not skip or delay doses without asking your provider.
When to Call Your Doctor
Call your healthcare provider if you develop a persistent cough, fever, painful urination, worsening abdominal pain, new rash, yellow skin or eyes, severe fatigue, swollen lymph nodes, or any symptom that feels unusual for you. You know your baseline better than anyone. If something feels off, say something.
Skyrizi Compared With Other Biologics
Skyrizi is often compared with other biologics used for psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. These may include TNF inhibitors, IL-17 inhibitors, IL-12/23 inhibitors, integrin blockers, and JAK inhibitors. Each class has different strengths, dosing schedules, monitoring needs, and safety concerns.
One reason Skyrizi is attractive for some patients is its targeted IL-23 mechanism and relatively convenient maintenance schedule. For plaque psoriasis and psoriatic arthritis, injections after the starter doses are typically spaced every 12 weeks. For inflammatory bowel disease, maintenance dosing is typically every 8 weeks after induction. For people who dislike frequent injections, that schedule may feel like a small mercy from the calendar gods.
Still, the “best” biologic is not the one with the nicest commercial or easiest dosing schedule. It is the one that fits your diagnosis, disease severity, previous treatment response, medical history, insurance access, safety profile, and personal preferences.
Frequently Asked Questions About Skyrizi
Is cancer a listed side effect of Skyrizi?
Cancer is not listed as a common side effect in U.S. prescribing information for Skyrizi, and Skyrizi is not currently known to cause cancer. However, people with a personal history of cancer should discuss individual risks with their healthcare provider.
Can Skyrizi weaken the immune system?
Skyrizi can reduce the immune system’s ability to fight infections. It does not shut down the immune system completely, but it does affect immune signaling enough that infection screening and symptom awareness are important.
Can I take Skyrizi if I have frequent infections?
Maybe, but this requires a careful risk-benefit discussion. People with chronic or recurrent infections should tell their healthcare provider before starting Skyrizi. Treatment may be delayed if an active infection is present.
Does Skyrizi require blood tests?
For Crohn’s disease and ulcerative colitis, liver enzymes and bilirubin are typically checked before treatment and during induction. Monitoring may continue afterward based on routine care and individual risk. For plaque psoriasis and psoriatic arthritis, monitoring requirements may be different, so follow your prescriber’s plan.
Can I stop Skyrizi if I feel better?
Do not stop Skyrizi without speaking with your healthcare provider. Symptoms may return if treatment is stopped, and restarting therapy may require a structured plan. Feeling better is the goal, not always the finish line.
Experience-Based Insights: What Taking Skyrizi May Feel Like in Real Life
Patient experiences with Skyrizi vary, but several practical themes come up often in real-world conversations about biologic treatment. The first is emotional hesitation. Many people feel nervous before the first dose, not because they dislike science, but because injecting a biologic or receiving an infusion can feel like crossing a medical bridge. Reading about side effects online can make that bridge look like it has fog, thunder, and maybe a troll underneath. A good healthcare team can make the process feel much less intimidating by explaining the schedule, teaching injection technique, and setting realistic expectations.
For someone with plaque psoriasis, the experience may begin with cautious hope. They may have tried topical creams, special shampoos, phototherapy, or other systemic treatments before Skyrizi. If plaques have affected visible areas such as the scalp, elbows, hands, or legs, the emotional burden can be heavy. People may avoid short sleeves, dark clothing, swimming pools, haircuts, or handshakes. When a biologic works well, improvement can feel bigger than clearer skin. It can feel like getting ordinary choices back.
For psoriatic arthritis, the experience may focus less on skin and more on movement. Morning stiffness, swollen fingers, sore feet, and joint pain can make simple tasks feel like tiny obstacle courses. Opening jars, typing, walking downstairs, or getting out of bed may become daily negotiations. A medication that reduces inflammation can improve quality of life, but patients should still pay attention to joint symptoms and communicate changes. Pain improvement does not always mean inflammation is fully controlled, and joint protection remains important.
For Crohn’s disease or ulcerative colitis, expectations may be more complex. People with inflammatory bowel disease often track symptoms closely: stool frequency, urgency, blood, abdominal pain, appetite, weight, fatigue, and anxiety about leaving the house. Starting Skyrizi may involve infusion appointments first, followed by at-home or clinic-based maintenance injections. The biggest practical adjustment is often planning: scheduling infusions, arranging transportation, checking insurance authorization, and keeping track of lab work. This is not glamorous, but neither is living your life around bathroom availability. Treatment logistics can be annoying, yet symptom control may be worth the calendar gymnastics.
Another common experience is learning to separate normal side effects from warning signs. A mild headache after treatment may not be alarming, but fever, persistent cough, painful urination, severe rash, yellowing of the skin or eyes, or swelling of the lips or throat requires medical attention. Patients often do better when they create a simple symptom checklist and know exactly whom to call after hours. The goal is not to become anxious about every sneeze. The goal is to be calmly prepared.
Insurance and cost can also shape the Skyrizi experience. Biologics are expensive, and many patients need prior authorization, copay support, specialty pharmacy coordination, or appeals. This administrative side can feel like a second diagnosis: paperworkitis. Keeping copies of approvals, denial letters, dosing instructions, and pharmacy contacts can save time and frustration.
Finally, many people discover that Skyrizi is not a solo act. Lifestyle habits still matter. Good sleep, smoking cessation, infection prevention, skin care, stress management, nutrition, and follow-up visits all support better outcomes. Skyrizi may be the headline treatment, but the supporting cast matters too.
Conclusion
Skyrizi is a targeted biologic treatment used for several immune-mediated inflammatory diseases, including plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. The main concern many patients have is cancer risk. Based on current information, Skyrizi is not known to cause cancer, and cancer is not listed as a common side effect. Still, people with a personal cancer history, unusual symptoms, or complex immune concerns should have a personalized discussion with their healthcare provider.
The more immediate safety issues with Skyrizi include infections, tuberculosis screening, serious allergic reactions, possible liver problems in Crohn’s disease and ulcerative colitis treatment, injection site reactions, headache, fatigue, fungal infections, joint pain, abdominal pain, anemia, fever, urinary tract infection, and rash. Most side effects are manageable, but serious symptoms should never be ignored.
Skyrizi can be life-changing for some patients, but it is not a casual medication. The safest approach is informed teamwork: understand the benefits, know the risks, complete recommended screening, keep follow-up appointments, and report unusual symptoms early. In other words, let Skyrizi do its jobbut keep your doctor in the group chat.
